International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Obesity and Hormones

Obesity and Hormones


Hormones are chemical messengers that regulate processes in our body. They are one factor in causing obesity. The hormones leptin and insulin, sex hormones and growth hormone influence our appetite, metabolism and body fat distribution. People who are obese have levels of these hormones that encourage abnormal metabolism and the accumulation of body fat. A system of glands, known as the endocrine system, secretes hormones into our bloodstream. The endocrine system works with the nervous system and the immune system to help our body cope with different events and stresses. Excesses or deficits of hormones can lead to obesity and on the other hand, obesity can lead to changes in hormones.

OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosted 69 open access articles Open Access articles, 260 Scientific conference Proceedings , 119 national symposiums and 155 speakers on Key word Hormones in Global Events page. Global Events of Conference series make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions of OMICS International Conferences.

Scope & Importance

The hormone leptin is produced by fat cells and is secreted into our bloodstream. Leptin reduces a person’s appetite by acting on specific centres of their brain to reduce their urge to eat. On-going research is looking at why leptin messages aren’t getting through to the brain in people who are obese. In a person who is obese, insulin signals are sometimes lost and tissues are no longer able to control glucose levels. This can lead to the development of type II diabetes and metabolic syndrome. The changes with age in the sex hormone levels of both men and women are associated with changes in body fat distribution. The pituitary gland in our brain produces growth hormone, which influences a person’s height and helps build bone and muscle. Growth hormone also affects metabolism. Researchers have found that growth hormone levels in people who are obese are lower than in people of normal weight. Obesity is also associated with low-grade chronic inflammation within the fat tissue. Excessive fat storage leads to stress reactions within fat cells, which in turn lead to the release of pro-inflammatory factors from the fat cells themselves and immune cells within the adipose (fat) tissue. Obesity is associated with an increased risk of a number of diseases, including cardiovascular disease, stroke and several types of cancer, and with decreased longevity (shorter life span) and lower quality of life.

People who are obese have hormone levels that encourage the accumulation of body fat. Behaviours such as overeating and lack of regular exercise, over time, reset the processes that regulate appetite and body fat distribution to make the person physiologically more likely to gain weight. Various studies have shown that a person’s blood leptin level drops after a low-kilojoule diet. Lower leptin levels may increase a person’s appetite and slow down their metabolism. This may help to explain why crash dieters usually regain their lost weight. It is possible that leptin therapy may one day help dieters to maintain their weight loss in the long term, but more research is needed before this becomes a reality.

Market Report

The obesity market is forecast to attain robust annual growth (21%) over the 2011–2021 forecast period; major-market sales will grow from $359 million to $2.4 billion. Novel emerging agents will experience rapid uptake owing to the high prevalence of obesity and the current lack of efficacious, safe and well-tolerated obesity drugs. Currently low diagnosis and drug-treatment rates will rise in response to the increase in available treatment options.

Relevant Conferences

Major Companies

  • Astral Pharmaceuticals
  • SRS Pharmaceuticals Pvt. Ltd.
  • ANI Pharmaceuticals Inc
  • AMPAC
  • The Chemistry Research Solution
  • Pharmatek 
  • Orion Corp 
  • Maine Biotechnology Services

This page will be updated regularly.

This page was last updated on March 28, 2024

Conference Series Destinations